Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
90,806,811
-
Share change
-
-807,850
-
Total reported value
-
$12,927,928,810
-
Put/Call ratio
-
72%
-
Price per share
-
$142.46
-
Number of holders
-
566
-
Value change
-
-$25,259,550
-
Number of buys
-
265
-
Number of sells
-
260
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q1 2015
As of 31 Mar 2015,
Edwards Lifesciences Corp - Common Stock (EW) was held by
566 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,806,811 shares.
The largest 10 holders included
VANGUARD GROUP INC, Capital Research Global Investors, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, BlackRock Institutional Trust Company, N.A., GENERATION INVESTMENT MANAGEMENT LLP, AQR CAPITAL MANAGEMENT LLC, BlackRock Fund Advisors, and Bank of New York Mellon Corp.
This page lists
567
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.